Biosimilar Drug Market

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In Biosimilar Drug Market is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

A biosimilar in Biosimilar Drug Market is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original ?innovator? products, and can be manufactured when the original product's patent expires.

Biosimilar Drug Market contains market size and forecasts of Biosimilar Drug in global, including the following market information:

Global Biosimilar Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Biosimilar Drug Market Sales, 2017-2022, 2023-2028, (K Dose)

Global top five Biosimilar Drug companies in 2021 (%)

The global Biosimilar Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biosimilar Drug include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech and Innovent. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilar Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biosimilar Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Dose)

Global Biosimilar Drug Market Segment Percentages, by Type, 2021 (%)

Injection

Tablets

Other Types

Global Biosimilar Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Dose)

Global Biosimilar Drug Market Segment Percentages, by Application, 2021 (%)

Ankylosing Spondylitis

Tumor

Rheumatoid Arthrtis

Cardiovascular

Other Application

Global Biosimilar Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Dose)

Global Biosimilar Drug Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biosimilar Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Biosimilar Drug revenues share in global market, 2021 (%)

Key companies Biosimilar Drug sales in global market, 2017-2022 (Estimated), (K Dose)

Key companies Biosimilar Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

CP Guojian Pharma

Biotech Pharma

Celgen Pharma

Henlius

Amgen

Eli Lilly

Sandoz

Changchun High Tech

Innovent